← Back to Discover
AH Capital Management, L.L.C.
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $14,214,935,834
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- SPACE EXPLORATION TECHN CORP · CLASS A COM STK · 84615Q103 · shares: $12,789,728,717
- NAVAN INC · CL A · 639193101 · shares: $645,361,120
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $172,503,421
- META PLATFORMS INC · CL A · 30303M102 · shares: $119,716,587
- FIGMA INC · CLASS A COM STK · 316841105 · shares: $108,238,042
- BIOAGE LABS INC · COM · 09077V100 · shares: $79,244,997
- BLOCK INC · CL A · 852234103 · shares: $77,268,972
- ERASCA INC · COM · 29479A108 · shares: $52,441,000
- MAZE THERAPEUTICS INC · COM · 578784100 · shares: $50,794,394
- DAMORA THERAPEUTICS INC · COM NEW · 36322Q206 · shares: $32,152,444
Reported holdings
19 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP | CLASS A COM STK | 84615Q103 | — | 74,855,020 shares | $12,789,728,717 |
| NAVAN INC | CL A | 639193101 | — | 28,218,676 shares | $645,361,120 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 921,099 shares | $172,503,421 |
| META PLATFORMS INC | CL A | 30303M102 | — | 212,531 shares | $119,716,587 |
| FIGMA INC | CLASS A COM STK | 316841105 | — | 5,983,308 shares | $108,238,042 |
| BIOAGE LABS INC | COM | 09077V100 | — | 3,233,170 shares | $79,244,997 |
| BLOCK INC | CL A | 852234103 | — | 1,016,697 shares | $77,268,972 |
| ERASCA INC | COM | 29479A108 | — | 2,862,500 shares | $52,441,000 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 1,702,225 shares | $50,794,394 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 1,236,157 shares | $32,152,444 |
| OMADA HEALTH INC | COM | 68170A108 | — | 1,153,639 shares | $25,322,376 |
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | — | 9,063,054 shares | $16,947,911 |
| ROBLOX CORP | CL A | 771049103 | — | 274,570 shares | $14,931,117 |
| AKTIS ONCOLOGY INC | COM | 01021M104 | — | 415,000 shares | $13,375,450 |
| CAMP4 THERAPEUTICS CORP | COM | 13463J101 | — | 2,125,339 shares | $9,287,731 |
| BITGO HOLDINGS INC | COM SHS CL A | 091947101 | — | 666,356 shares | $3,451,724 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 140,000 shares | $3,084,200 |
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | — | 108,568 shares | $1,075,909 |
| IP STRATEGY HOLDINGS INC | COM | 42727R302 | — | 4,137 shares | $9,722 |